In turn, Porsche et al. revealed that dendritic cells in the adipose tissue are more potent activators of CD4+ T-cells compared to ATMs and that blocking CD4+ T-cell activation in AT by reducing MHC2 on dendritic cells does not affect chronic low grade inflammation in adipose tissue with obesity [28]. This evidence concerns the gene CD4 and obesity disorder.